Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 39
Filtrar
1.
Diabetes Res Clin Pract ; 94(3): 463-7, 2011 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-21955960

RESUMEN

OBJECTIVE: To examine change of diagnosis in patients from the German/Austrian multicenter DPV (Diabetes Patienten Verlaufsdokumentation) database initially classified as type 2 diabetes. METHODS: Patients aged ≤20 years at onset, diagnosed between 1995 and 2010 were followed for at least 6 months. Chi-square/Wilcoxon tests were performed to compare patient groups according to diabetes type after reclassification. RESULTS: From 580 study patients, 60 (10.3%) were reclassified, on average 2.4 years after initial diagnosis as follows: 23 (38.3%) as type 1 diabetes; 9 (15%) as maturity onset diabetes of the young (MODY); 20 (33.3%) as "other specific diabetes forms" and 8 (13.3%) as "remission" of type 2 diabetes. Patients reclassified to type 1 were significantly younger (13.5 ± 2.9 versus 14.0 ± 2.6; p=0.027) and more often ß-cell antibody positive at disease onset (80.0% versus 31.2%; p=0.002), while patients reclassified as MODY had significantly lower BMI-SDS values than 520 patients with confirmed type 2 diabetes (2.5 ± 1.1 versus 0.9 ± 1.1; p<0.001). The latter were also considerably more obese than patients in "remission" and those reclassified to "other specific diabetes forms". CONCLUSION: About 10% of patients in the DPV database, initially diagnosed as type 2 diabetes, were retrospectively reclassified.


Asunto(s)
Diabetes Mellitus Tipo 2/clasificación , Diabetes Mellitus Tipo 2/diagnóstico , Adolescente , Adulto , Edad de Inicio , Austria/epidemiología , Bases de Datos Factuales , Diabetes Mellitus Tipo 2/epidemiología , Femenino , Estudios de Seguimiento , Alemania/epidemiología , Humanos , Masculino , Estudios Prospectivos , Estudios Retrospectivos , Adulto Joven
2.
J Org Chem ; 75(11): 3859-62, 2010 Jun 04.
Artículo en Inglés | MEDLINE | ID: mdl-20429525

RESUMEN

For the first time, fully fledged phthalocyanines (Pcs) were ex post glycoconjugated, that is, via 1,3-dipolar cycloaddition reaction. This divergent approach gains rapid access to a broad range of highly diverse Pcs bearing chemically sensitive substituents. This will be a breakthrough in generating structure-activity relationships (SAR) for the development of novel bioactive molecules.


Asunto(s)
Indoles/química , Glicosilación , Isoindoles , Fármacos Sensibilizantes a Radiaciones , Relación Estructura-Actividad
3.
Tissue Antigens ; 68(2): 147-52, 2006 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-16866884

RESUMEN

Type 1 diabetes is an autoimmune heterogeneous disease that is determined by environmental and genetic factors. A possible retroviral etiology has been inferred from the observation that human endogenous retrovirus (HERV)-K18 encoding a superantigen (SAg) has a polymorphism associated with this disease. Type 1 diabetes families from Germany and Belgium were genotyped for the novel HERV-8914 (303 families) and for the known HERV-8594 (284 families) polymorphisms within the SAg-coding region on the HERV-K18. Case-control analysis was performed for the HERV-8914 polymorphism (506 patients) and for the HERV-8594 polymorphism (370 patients) and compared with 350 German controls. Haplotypes were constructed. Additionally, a microsatellite within the CD48 gene was analyzed in German type 1 diabetes families (n=125) as well as in patients (n=375) and in healthy controls (n=350). No association was found for HERV-K18 polymorphisms or the CA repeat within the CD48 gene with type 1 diabetes mellitus either in families or by comparing patients and controls. In conclusion, we cannot confirm a role of HERV-K18 polymorphisms -HERV-8914 and HERV-8594- or of the CD48 CA repeat for type 1 diabetes susceptibility.


Asunto(s)
Antígenos CD/genética , Diabetes Mellitus Tipo 1/genética , Retrovirus Endógenos/genética , Proteínas de la Membrana/genética , Superantígenos/genética , Antígeno CD48 , Estudios de Casos y Controles , Niño , Preescolar , Repeticiones de Dinucleótido , Femenino , Predisposición Genética a la Enfermedad , Genotipo , Humanos , Intrones/genética , Desequilibrio de Ligamiento , Masculino , Polimorfismo Genético , Programas Informáticos
4.
Eur J Immunogenet ; 29(4): 321-30, 2002 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-12121278

RESUMEN

Genes of the HLA-DR, DQ region confer strong susceptibility to type 1 diabetes mellitus (IDDM). A possible mechanism of susceptibility is a difference in the amounts of transcripts of predisposing and neutral or protective haplotypes. In this study we developed an assay to compare the amounts of mRNA of two distinct HLA-DQA1 alleles in peripheral blood lymphocytes (PBLs) of heterozygous individuals, using a quantitative RT-PCR with an internal standard covering all HLA-DQA1 specifities. We also developed an algorithm to calculate the amounts of mRNA for two distinct alleles in heterozygous individuals based on the comparison to the same internal standard. In total, 37 HLA-DQA1 heterozygous individuals were analysed, including patients with IDDM (n = 14) and healthy controls (n = 23). Intra-individually, we observed different amounts of mRNA for different HLA-DQA1 alleles in the order: HLA-DQA1*03 > *01 > *0201 > *05. This order was observed in all individuals. We also observed a variation in the ratio of these unbalanced amounts of mRNA in individuals with the same HLA-DQA1 allele combinations. In all allele combinations the average ratio was increased in patients with IDDM compared to the control samples. HLA-DQA1*03 positive and DQA1*03, *05 heterozygous patients had the highest average ratios. Nevertheless, based on limited sample numbers, these differences did not reach significance. We therefore conclude that variations between HLA-DQA1 alleles are not limited to the nucleotide sequence but are also found at the level of amounts of mRNA.


Asunto(s)
Diabetes Mellitus Tipo 1/genética , Antígenos HLA-DQ/genética , ARN Mensajero , Diabetes Mellitus Tipo 1/inmunología , Cadenas alfa de HLA-DQ , Heterocigoto , Humanos , ARN Mensajero/metabolismo , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa
5.
Eur J Immunogenet ; 29(1): 73-4, 2002 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-11841494

RESUMEN

A point mutation in the leukocyte common antigen (CD45, C-->G77, exon 4) was investigated in patients with type 1 diabetes (IDDM), patients with Graves' disease and controls. The distribution did not differ significantly between patients and controls. This CD45 variant does not therefore confer susceptibility to either IDDM or Graves' disease.


Asunto(s)
Diabetes Mellitus Tipo 1/genética , Predisposición Genética a la Enfermedad , Enfermedad de Graves/genética , Antígenos Comunes de Leucocito/genética , Exones , Humanos , Proteína Tirosina Fosfatasa no Receptora Tipo 1
6.
Rehabilitation (Stuttg) ; 40(5): 280-8, 2001 Oct.
Artículo en Alemán | MEDLINE | ID: mdl-11579375

RESUMEN

Effects of Treatment in Mother-Child Rehabilitation Centres. The study aims at an external evaluation of mother-child rehabilitation centres in Germany. The centres taking part in the project will get detailed information about their present state of quality in the dimensions of structure, process and outcome as well as patient satisfaction and job satisfaction of the employees. This article focuses on quality of outcome. Two main questions are addressed: How do women treated in mother-child rehabilitation centres assess their health problems at admission, and what are the effects after three weeks of inpatient treatment? The results show that in comparison with a German norm population, 55 % to 75 % of the women in the present study reported intense distress in all dimensions of health (somatic, functional and psychosocial). The analysis of effects after treatment confirms a distinct improvement of health status reported by patients as well as by doctors and therapists. Data of a follow-up after 6 months will show whether these positive effects can be maintained.


Asunto(s)
Relaciones Madre-Hijo , Trastornos Psicofisiológicos/rehabilitación , Centros de Rehabilitación , Trastornos Somatomorfos/rehabilitación , Gestión de la Calidad Total , Adulto , Niño , Femenino , Identidad de Género , Alemania , Humanos , Masculino , Evaluación de Procesos y Resultados en Atención de Salud , Satisfacción del Paciente , Trastornos Psicofisiológicos/psicología , Trastornos Somatomorfos/psicología
7.
Clin Endocrinol (Oxf) ; 54(3): 335-8, 2001 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-11298085

RESUMEN

OBJECTIVE: Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) is a rare systemic autoimmune disorder of monogenic and autosomal-recessive inheritance. To date, 29 APECED causing mutations have been identified in the responsible gene AIRE-1, coding for a regulator of transcription. The aim of this study was to examine whether mutations in AIRE-1, in their heterozygous form, predispose to the more common isolated autoimmune endocrinopathies Addison's disease, type 1 diabetes mellitus, Graves' disease and Hashimoto's thyroiditis. DESIGN: Patients with isolated autoimmune endocrine disorders as well as healthy controls were analysed for two of the most common AIRE-1 mutations, mutation R257X in exon 6 and a 13-bp deletion in exon 8. Mutations were detected by polymerase chain reaction based techniques. PATIENTS: In total, 726 individuals were investigated for mutation R257X. Subjects comprised patients with Addison's disease, IDDM, Graves' disease and Hashimoto's thyroiditis. With regard to the 13 bp deletion we could screen 91 patients with Addison's disease. In addition, six patients with the APECED syndrome including one family were analysed for both mutations. RESULTS: Out of the 12 alleles in APECED patients six contained either mutation R257X or the 13 bp deletion, confirming that these mutations prevail in Europe. R257X was found in one subject with Hashimoto's thyroiditis in its heterozygous form. The 13 bp deletion was not detected in any subject with Addison's disease. CONCLUSIONS: The two studied AIRE-1 mutations are so rare in the general population that they can not contribute to susceptibility for the more common isolated autoimmune disorders.


Asunto(s)
Enfermedad de Addison/genética , Diabetes Mellitus Tipo 1/genética , Enfermedad de Graves/genética , Poliendocrinopatías Autoinmunes/genética , Tiroiditis Autoinmune/genética , Factores de Transcripción/genética , Análisis Mutacional de ADN , Predisposición Genética a la Enfermedad , Pruebas Genéticas , Humanos , Proteína AIRE
8.
Tissue Antigens ; 55(3): 271-4, 2000 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-10777104

RESUMEN

HLA-DR4 is a primary disease association marker in type 1 diabetes mellitus (IDDM). We therefore analyzed the transmission of 228 DR4+ haplotypes in 183 families with an IDDM proband (95 from Germany and 88 from Belgium). In a separate case-control data set, we investigated the HLA-DRB1*04 and DQ allele distribution in 245 IDDM patients and 177 controls from Germany, all DR4 positive. HLA-DRB1 *0401 and *0402 linked to DQB1 *0302 were significantly more often transmitted to patients in the studied families (81% and 89%) in contrast to DRB1 *0401-DQB1 *0301 (33%). The case-control study of HLA-DQB1 *0302+ individuals revealed -DRB1 *0405 to be more frequent in patients with IDDM and HLA-DRB1 *0403 and -DRB1 *0404 to be less frequent. HLA-DQA1 *0102-DQB1 *0602 and -DQA1 *0501-DQB1 *0301 in trans complementation with DRB1 *0401-DQB1 *0302 were also significantly less frequent in IDDM patients (P<3x 10(-7) and P<0.02). In conclusion, HLA-DRB1 *0403 and -DQB1*0301 alleles in cis as well as protective DQ haplotypes in trans, confer dominant protection against IDDM in a German / Belgian population.


Asunto(s)
Diabetes Mellitus Tipo 1/genética , Predisposición Genética a la Enfermedad/genética , Antígenos HLA-DR/genética , Adolescente , Adulto , Bélgica , Estudios de Casos y Controles , Niño , Preescolar , Diabetes Mellitus Tipo 1/inmunología , Susceptibilidad a Enfermedades , Femenino , Alemania , Antígenos HLA-DQ , Cadenas alfa de HLA-DQ , Cadenas beta de HLA-DQ , Cadenas HLA-DRB1 , Humanos , Lactante , Masculino
9.
Autoimmunity ; 31(1): 67-72, 1999.
Artículo en Inglés | MEDLINE | ID: mdl-10593571

RESUMEN

Vitamin D has been shown to modulate the immune system thereby preventing the development of diabetes in NOD mice. Since the vitamin D binding protein (DBP) is the main transporter for vitamin D and DBP has immunomodulatory properties itself, we investigated three polymorphic sites within the DBP gene as candidates for type 1 diabetes susceptibility for the first time. 152 Caucasian families with at least one affected offspring were genotyped for intron 8 [(TAAA)n repeat] and exon 11 (HaeIII, StyI) polymorphisms. Transmission disequilibrium testing was used to detect preferential transmission to affected offspring. We found no significant transmission disequilibrium for DBP alleles. The strongest deviation from expected values was observed for the "10" allele (relative risk = 0.57, transmitted 13 of 36 times (corrected p = 0.249)). Although we cannot exclude an association of the studied DBP alleles with type 1 diabetes at present, these data do not suggest their contribution to this disease in Germans.


Asunto(s)
Alelos , Diabetes Mellitus Tipo 1/genética , Predisposición Genética a la Enfermedad/genética , Desequilibrio de Ligamiento/genética , Proteína de Unión a Vitamina D/genética , Cromosomas Humanos Par 1/genética , Familia , Femenino , Alemania , Haplotipos , Humanos , Masculino , Reacción en Cadena de la Polimerasa , Polimorfismo Genético , Población Blanca/genética
11.
Angew Chem Int Ed Engl ; 38(16): 2372-2375, 1999 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-10458790

RESUMEN

Primary and unbranched secondary amines are obtained by the highly selective hydroaminomethylation of olefins with ammonia [Eq. (a)]. The selectivity is readily controlled with a new dual Rh/Ir catalyst in a two-phase system.

12.
J Clin Endocrinol Metab ; 84(4): 1404-8, 1999 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-10199786

RESUMEN

Major genetic susceptibility to type 1 diabetes mellitus maps to the human leukocyte antigen (HLA) region on chromosome 6p. During evolution, endogenous retroviral long terminal repeats (LTR) have been integrated at several sites within this region. We analyzed the presence of a solitary HERV-K LTR in the HLA DQ region (DQ-LTR3) and its linkage to DRB1, DQA1, and DQB1 haplotypes derived from 246 German and Belgian families with a patient suffering from type 1 diabetes mellitus. Segregation analysis of 984 HLA DQA1/B1 haplotypes showed that DQ-LTR3 is linked to distinct DQA1 and DQB1 haplotypes but is absent in others. The presence of DQ-LTR3 on HLA DQB1*0302 haplotypes was preferentially transmitted to patients from heterozygous parents (82%; P < 10(-6)), in contrast to only 2 of 7 DQB1*0302 haplotypes without DQ-LTR3. Also, the extended HLA DRB1*0401, DQB1*0302 DQ-LTR3-positive haplotypes were preferentially transmitted (84%; P < 10(-6)) compared with 1 of 6 DR-DQ matched DQ-LTR3 negative haplotypes. DQ-LTR3 is missing on most DQB1*0201 haplotypes, and those LTR3 negative haplotypes were also preferentially transmitted to patients (80%; P < 10(-6)), whereas DQB1*0201 DQ-LTR3-positive haplotypes were less often transmitted to patients (36%). Other DQA1/B1 haplotypes did not differ for DQ-LTR3 between transmitted and nontransmitted haplotypes. Thus, the presence of DQLTR3 on HLA DQB1*0302 and its absence on DQB1*0201 haplotypes are independent genetic risk markers for type 1 diabetes.


Asunto(s)
Diabetes Mellitus Tipo 1/genética , Retrovirus Endógenos/genética , Predisposición Genética a la Enfermedad , Antígenos HLA-DQ/genética , Haplotipos , Secuencias Repetidas Terminales , Femenino , Heterocigoto , Humanos , Masculino
13.
Diabetes ; 48(1): 215-8, 1999 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-9892247

RESUMEN

Recently, human endogenous retrovirus type K (HERV-K [IDDMK(1,2)22]) was isolated from an IDDM patient's beta-cell supernatant and shown to be implicated in expression as a superantigen. Furthermore, HERV-K RNA was found in plasma samples from newly diagnosed patients but not in those from healthy control subjects. We had earlier identified the presence of a HERV-K long terminal repeat element of the HLA DQ gene (DQ-LTR) to be positively associated with IDDM, which led us to investigate whether DQ-LTR is related to transcription of the putative retroviral superantigen. Additionally, we sought immunological evidence to determine whether those retroviral antigens could evoke an antibody response. Patients with IDDM (n = 14), Hashimoto's thyroiditits (n = 5), and Graves' disease (n = 12), as well as healthy control subjects (n = 12), were investigated, as were four nuclear families of Graves' disease patients and two of IDDM patients. RNA was isolated from plasma and peripheral blood lymphocytes and subjected to reverse transcription-polymerase chain reaction for transcripts of the env region of the HERV-K (IDDMK(1,2)22) sequence. We identified env transcripts in both plasma and peripheral blood lymphocytes in all individuals studied: patients with recent-onset or long-standing IDDM, their relatives, and healthy control subjects, as well as patients with thyroid autoimmune disorders. Furthermore, we screened the sera of patients (n = 62) and control subjects (n = 35) for evidence of humoral immunity against HERV-K by Western blot specific for the ENV protein. Similar frequencies of antibody-positives were observed both in patients with IDDM (29%) and in healthy control subjects (26%). We conclude that neither the ubiquitous HERV-K transcripts nor the comparable percentage of ENV protein antibodies are associated with IDDM. An earlier, presymptomatic antibody response against HERV-K (IDDMK(1,22)22) ENV cannot be ruled out. However, the superantigen hypothesis of an endogenous retrovirus in beta-cell autoimmunity awaits confirmation.


Asunto(s)
Diabetes Mellitus Tipo 1/inmunología , Diabetes Mellitus Tipo 1/virología , ARN Mensajero/metabolismo , ARN Viral/metabolismo , Retroviridae/metabolismo , Proteínas del Envoltorio Viral/inmunología , Formación de Anticuerpos/fisiología , Western Blotting , Diabetes Mellitus Tipo 1/genética , Humanos , Valores de Referencia , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Proteínas del Envoltorio Viral/metabolismo
14.
Eur J Pediatr ; 157(11): 912-8, 1998 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-9835436

RESUMEN

UNLABELLED: In 71 children with familial hypercholesterolaemia the effect of dietary and/or medical treatment was evaluated. Initial total cholesterol and low density lipoprotein (LDL)-cholesterol levels were significantly lower in children who were consecutively treated by diet (Step-One-Diet) than in those who received additional medication. By dietary treatment, the median total cholesterol level (236.5 mg/dl; range 210-510 mg/dl) was reduced by 7.4% and the median LDL-cholesterol level (162 mg/dl; range 126-423 mg/dl) by 9.9%. By dietary and medical therapy, the median total cholesterol level (330 mg/dl; range 270-424 mg/dl) was reduced by 29.7% and the median LDL-cholesterol level (263 mg/dl; 192-333 mg/dl) by 25.9%. High density lipoprotein (HDL)-cholesterol and HDL 3 remained unchanged. HDL 2 showed a significant decrease of 15.6% up to 27 mg/dl (13-42 mg/dl) on medical treatment. Apolipoprotein A I levels did not change during therapy. Initial apolipoprotein B levels were significantly higher in children who were treated by diet and medication and were reduced by 28.9% by combined therapy. In 28 patients (39.4%) an excess of lipoprotein (a) was detected. Regarding the apolipoprotein E phenotype, 32.2% of the patients carried the risk gene epsilon4 in a hetero- or homozygous form. CONCLUSION: Early dietary and/or medical treatment in hypercholesterolaemic children significantly ameliorates the lipoprotein status. The pretherapy lipoprotein status seems to prognosticate the effectiveness of therapy.


Asunto(s)
Hiperlipoproteinemia Tipo II/sangre , Hiperlipoproteinemia Tipo II/tratamiento farmacológico , Hiperlipoproteinemia Tipo II/terapia , Lípidos/sangre , Lipoproteínas/sangre , Adolescente , Adulto , Apolipoproteínas/sangre , Niño , Preescolar , HDL-Colesterol/sangre , LDL-Colesterol/sangre , Femenino , Humanos , Hiperlipoproteinemia Tipo II/dietoterapia , Lactante , Recién Nacido , Masculino , Estudios Retrospectivos , Triglicéridos/sangre
18.
Clin Chem ; 44(7): 1388-96, 1998 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-9665414

RESUMEN

Familial apolipoprotein (apo) CII deficiency is a rare autosomal recessive inborn error of metabolism clinically resembling lipoprotein lipase deficiency. A number of mutations of the apo CII gene are known to date; they are located in the promoter region, the coding exons, or in the splice junctions. We present a simple assay based on PCR and denaturing gradient gel electrophoresis, which allows scanning of the promoter, the entire coding sequence, and the splice junctions of the apo CII gene for sequence variants. All gene fragments are amplified using a common PCR protocol and are examined for mutations on a single gradient gel. Using this method and direct sequencing, we identified homozygosity for a donor splice-site mutation in the second intron, previously designated apo CII-Hamburg, as the genetic cause of apo CII deficiency in a 9-year-old boy presenting with chylomicronemia, eruptive xanthoma, and pancreatitis. In addition, the method allowed us to detect all of six different other known mutations of the apo CII gene. We conclude, therefore, that our assay is highly sensitive; in addition, it is easy to perform and may facilitate the differential diagnosis of disorders of lipoprotein metabolism at the genetic level.


Asunto(s)
Empalme Alternativo , Apolipoproteínas C/genética , Hiperlipoproteinemia Tipo IV/genética , Mutación , Apolipoproteína C-II , Apolipoproteínas C/sangre , Preescolar , Quilomicrones/sangre , Electroforesis en Gel de Poliacrilamida/métodos , Humanos , Hiperlipoproteinemia Tipo IV/sangre , Intrones , Masculino , Linaje , Reacción en Cadena de la Polimerasa , Regiones Promotoras Genéticas , Reproducibilidad de los Resultados , Sensibilidad y Especificidad
20.
Z Arztl Fortbild Qualitatssich ; 91(3): 233-42, 1997 Jun.
Artículo en Alemán | MEDLINE | ID: mdl-9312428

RESUMEN

Type I diabetes, the most common endocrinological disease in children and adolescents, is nowadays considered to be a genetically linked autoimmune disease. Clinical progression is divided into 3 phases: initial, remission and post-remission. Therapy consists of ketoacidotic compensation (when necessary), initial insulin dose adjustment, an organised education programme, and conventional insulin treatment with a mixture of normal and long-acting human insulins. Older children and adolescents (from age 12, or better, from age 14) are mostly treated with intensive conventional insulin therapy (ICT). The necessary long-term care of children and adolescents with diabetes should be carried out by a pediatric diabetic team. This team is in the position to recognise the special age-related problems in these patients and, based on adequate experience, can guarantee the best possible treatment. The aim must be the optimal, virtually near-normoglycaemic metabolic control already in childhood so as to avoid the threat of diabetic complications or at least to delay their onset.


Asunto(s)
Diabetes Mellitus Tipo 1/terapia , Adaptación Psicológica , Adolescente , Niño , Terapia Combinada , Diabetes Mellitus Tipo 1/complicaciones , Diabetes Mellitus Tipo 1/psicología , Dieta para Diabéticos/psicología , Relación Dosis-Respuesta a Droga , Esquema de Medicación , Humanos , Insulina/administración & dosificación , Insulina/efectos adversos , Grupo de Atención al Paciente , Pronóstico , Rol del Enfermo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...